Sherbrooke Park Advisers’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$287K	Buy	+7,882	New	+$287K	0.12%	315
2025 Q1	–	Sell	-10,387	Closed	-$437K	–	872
2024 Q4	$437K	Buy	+10,387	New	+$437K	0.14%	262